Riskpilot← Back to searchSign inGet full accessELLINGSRUDLEGENE AS
ASActiveOrg 924896752Lindeberg Næringsvei 10, 1067 OsloGeneral medical practice activities · NACE 8621Est. 20202 employees
Revenue 2024
NOK 3,6M
+4% vs 2023
EBITDA margin
10.5%
+491% vs 2023
Equity ratio
62.5%
Financial strength
Net profit 2024
NOK 291K
+650% vs 2023
| Revenue | NOK 3,6M | +4% |
| EBITDA | NOK 380K | +491% |
| Net profit | NOK 291K | +650% |
| Total assets | NOK 891K | +7% |
| Equity | NOK 557K | +109% |
| Employees | 2 | — |
Legal name
ELLINGSRUDLEGENE AS
Org number
924896752
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
3. april 2020
Share capital
NOK 30 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap eller styrets leder og ett styremedlem i fellesskap.
Company purpose
Drift av legesenter og virksomhet som står i forbindelse med det og andre produkter/tjenester som naturlig hører til dette, herunder å delta i andre selskap med lignende virksomhet, og kjøp og salg av aksjer eller på annen måte gjøre seg interessert i andre foretak. Selskapet kan også drive med kjøp/drift av fast eiendom.
Address
Lindeberg Næringsvei 10, 1067 Oslo
Phone
+4722905460
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 816 | 2 659 | 2 880 | 3 471 | 3 603 |
| Staff expenses | −471 | −992 | −1 053 | −1 134 | −973 |
| EBITDA | 484 | −65 | 82 | 64 | 380 |
| Depreciation & amort. | −55 | −73 | −81 | −28 | −24 |
| EBIT | 429 | −137 | 1 | 37 | 356 |
| Net financials | 0 | 0 | 1 | 2 | 6 |
| Profit before tax | 429 | −137 | 2 | 39 | 362 |
| Tax | 97 | −0 | −0 | −0 | 72 |
| Net profit | 333 | −137 | 2 | 39 | 291 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 910 | 698 | 708 | 835 | 891 |
| Equity | 363 | 225 | 227 | 266 | 557 |
| Long-term debt | 353 | 339 | 360 | 360 | 0 |
| Short-term debt | 195 | 133 | 121 | 209 | 335 |
| Total debt | 548 | 472 | 481 | 569 | 335 |
EBITDA margin
10.5%
This company
15.8%
Market median
-34% vs market
20202024
Equity ratio
62.5%
This company
38.2%
Market median
+64% vs market
20202024
Return on equity
52.2%
This company
18.4%
Market median
+184% vs market
20202024
Net profit margin
8.1%
This company
8.1%
Market median
+0% vs market
20202024
Asset turnover
4.04×
This company
1.12×
Market median
+261% vs market
20202024
Debt / equity
0.60×
This company
0.62×
Market median
+3% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-03-31 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ELLINGSRUDLEGENE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eva Marianne Sponnich | Chairman | 0 companies |
| Kristin Lan Ngoc Thi Le | Board of Directors | 0 companies |
| Kathrine Holth Schaathun | Board of Directors | 0 companies |